Medical

The Productivity Paradox: Can AI Fix Pharma’s R&D Crisis?

Despite a $145.5 billion investment in pharmaceutical R&D in 2023, US Federal Drug Administration novel drug approvals remain stagnant at around 43 annually, according to recent findings from Deloitte’s 14th Annual Pharmaceutical Innovation Report. The complexity of modern diseases, combined

Vital Signs: How Wearables Are Redefining Personal Health

In recent years, Internet-enabled wearable devices have emerged as powerful tools for monitoring and managing personal health, promising to revolutionize healthcare delivery. As these technologies have become more affordable and user-friendly, their adoption has skyrocketed – in 2022 alone, over